The global home medical equipment consumption pattern will depend on demographic and epidemiological development. Increased efforts in the fight against chronic illnesses such as respiratory diseases, kidney disorders, and cancer will boost the demand for home therapeutic devices. Products such as portable oxygen concentrators, continuous positive airway products, ventilators, and other accessories will undergo the fastest growth in sales in this market. Increasing numbers of baby boomers and an increase in the population of aged people on a global scale will also assist in the growth of this market.

Development in the convenience in handling and usage of these equipments due to the increase in chronically ill patients will create a rapid increase in demand. The home IV devices segment will also experience upward growth as intense control in outpatient visits and shorter hospital stays will lead to an increase in the number of cancer and other chronic disease patients to be administered parenteral nutrition, and other therapeutic modalities at home.

It is estimated that the U.S. will be the largest market for home medical equipments owing to its wide base of home healthcare equipment providers, good reimbursement policies, better healthcare infrastructure and high healthcare expenditure. Moreover, the recent changes in the healthcare industry due to ‘Obamacare’ will also boost the demand for such equipment, since almost 30 million uninsured Americans will now enjoy medical coverage.

Emerging economies such as the BRIC countries will be the fastest growing market for such products as the economic condition of such countries is rapidly improving. On the other hand, the already developed markets of Europe, Canada, Japan, Australia, and South Korea will show fair demand for therapeutic, monitoring, and support products as the sales levels in these markets will rise.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...

The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs. Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical trials and thus their commercial life is far less (approximately 15 years). After the patent expiry the manufacturers of such drugs face intense pricing pressure because of the competition from their cheap generic counterparts.

Sale of generic drugs also holds importance for entities such as wholesalers, pharmacies, and pharmacy benefit managers, as the sale of generic drugs provides higher profit margins than the sale of branded drugs. The generic drugs market is classified as simple generics, super-generics and biosimilars. Furthermore, the generic drugs market can be classified on the basis of their therapeutic applications such as anti-infective drugs, central nervous system drugs, cardiovascular products, anti-arthritis drugs, respiratory products, anti-cancer drugs and others. 

Geographically, North America is the largest consumer and manufacturer of generic drugs. In addition, the highest growth in this market is observed in Asia-Pacific. 

Some of the major generic drugs manufacturers include pharmaceutical companies such as Dr. Reddy’s Laboratories, Actavis, Mylan, Inc., Apotex, Inc., Ranbaxy Laboratories, Ltd, Hospira, Inc., Par Pharmaceutical, Inc., Sandoz International GmbH, Teva Pharmaceutical Industries, Ltd., Watson Pharmaceuticals, Ltd. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...